Coripharma
PrivateLast Round
Early Funding
Apr 26, 2023
Total Funding Raised
$38.96M
Company Overview
Coripharma operates in Healthcare & Life Sciences and is based in Iceland. Its latest recorded funding round was an Early Funding round in April 2023.
Coripharma is a pharmaceutical company that specializes in the development, out-licensing, and contract manufacturing of generic solid oral dosage forms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Quality Management
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coripharma Comparables
Compare Coripharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adragos Pharma | 80% | |
| Medichem S.A. | 74% | |
| Recipharm | 71% |
For institutional investors. Book with your work email.
Coripharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 26, 2023 | ||||
| Early Funding | Feb 15, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Grew 22% QoQ, from 93 to 113 employees.
- Apr 26, 2023
$11M raised from idunn enterprise fund, tfii slhf, and VÍS.
For institutional investors. Book with your work email.
Coripharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Coripharma's valuation, stock price, and market status.
Is Coripharma a public or private company?
Coripharma is a private company.
What is the current stock price of Coripharma?
Coripharma is a private company, so its shares have no public market price. Caplight tracks Coripharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Coripharma worth (valuation)?
Valuation information for Coripharma is not publicly available.
Can I buy Coripharma stock?
Coripharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Coripharma's last funding round?
Coripharma's most recent funding round was Early Funding on April 26, 2023.
Who are the main investors in Coripharma?
Investor information for Coripharma is not publicly disclosed.
Will Coripharma IPO soon?
No public IPO plans have been announced for Coripharma.
How can I track Coripharma secondary market activity?
Caplight tracks bids, offers, and trades in Coripharma's shares on secondary markets.